Artificial Neural Networks working with Image Guided Therapies to improve heart disease treatment

By Rashed Karim Research Fellow at King’s College London School of Biomedical Engineering and Imaging Sciences It’s exciting to envisage that future treatments for cardiovascular disease will be supported by intelligent systems and devices. At the...

Preparations for AI patenting in Europe

The current era of rapid technological development requires industry to be quick to respond to challenges and opportunities, with many choosing to exploit new AI technologies rather than wait to be disrupted by competitors. Intellectual...

Cutting to the chase – how a folded piece of paper is saving lives

Around the world, many hundreds of millions of people are infected by parasitic diseases such as malaria and schistosomiasis. Many more millions of people are affected by the impact of these diseases with profound...

The body in miniature

By Craig Brierley at University of Cambridge The past few years has seen an explosion in the number of studies using organoids – so-called ‘mini organs’. While they can help scientists understand human biology and...

Patent Protection of Medical Devices – Time for a Rethink?

Christopher Burnett,  Patent Attorney,  AA Thornton The duration of patent protection for medical devices is up to twenty years, as for any other type of device. Pharmaceuticals, on the other hand, may be entitled to an...

Drug delivery market witnesses significant growth

Developing new ways of delivering drugs has become big business with companies now investing many millions of pounds in seeking the next big breakthrough. Indeed, market analysts Mordor Intelligence estimates in a new report that the...

Replace FBS with Human Platelet Lysate

The manufacture of clinical-grade cellular products often requires ex vivo culture and expansion of human cells. Fetal bovine serum (FBS) is frequently used as a supplement to basal cell culture media during expansion; however, its...

Remarkable breakthroughs that herald the age of bionics

He was one of the television hits of the 1970s, the Six Million Dollar Man with his super-enhanced vision and reconstructed bionic limbs that allowed him to run at incredible speeds and jump huge...

Investment supports American projects

Stem cell agency, The California Institute for Regenerative Medicine (CIRM) has awarded $19.9 million to ImmunoCellular Therapeutics to carry out a Phase 3 clinical trial in people with newly diagnosed glioblastoma using a kind...

Conference to turn spotlight on biosimilars market

Biologics and biosimilars researchers from around the globe will gather for the 7th European Biosimilars Congress 2017 in Munich between May 15-17. The congress will bring together everyone from scientists, researchers and business development managers to...

Accreditation: Delivering Confidence in Health Services

The quality of health and social care services is under constant and close scrutiny.  Professor Sir Mike Richards, Chief Inspector of Hospitals at the Care Quality Commission (CQC) has recently acknowledged that accreditation and...

How chromosomes find a happy medium

By Sabrina Richards Staff writer at Fred Hutchinson Cancer Research Center Hutch scientists show how chromosomes communicate to balance crossovers during sex-cell formation Scientists at Fred Hutchinson Cancer Research Center have worked out the molecular underpinnings of...

90 years on, the time-bomb of antibiotic resistance

By Professor Colin Garner The events of 28 September 1928 could justifiably lay claim to being called the most significant breakthrough in medical history. With typical ingenuity and a quantity of genius, Sir Alexander Fleming discovered...

Auto Injectors: Customer needs and future trends

Pharmaceutical industry might well be one of the most exacting industries on the market. In order to satisfy a very broad range of stakeholders, including patients, prescribers, payers, patient-care providers and other healthcare professionals,...

Helping everyone breathe easier – finding new approaches to treating respiratory disease

Everyone should be able to breathe clean air with healthy lungs, yet sadly far too many people continue to gasp for breath because of lung disease. In the UK, one in five people develop...

But what of the future?

So nanotechnology is already producing developments but what is its potential? Well, the opportunities are huge and the work already under way could just be the start. For example, the science could greatly speed up...